Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment

E-poster session
Chairs: P. Molyneaux (London, United Kingdom), M. Bonifazi (Ancona (AN), Italy)

Efficacy of antifibrotics in chronic hypersensitivity pneumonitis. A 3 year real-life observational study V. Tzilas (Athens, Greece), A. Tzouvelekis (Athens, Greece), E. Bouros (Athens, Greece), T. Karampitsakos (Athens, Greece), M. Ntassiou (Athens, Greece), E. Avdoula (Athens, Greece), A. Trachalaki (Athens, Greece), K. Antoniou (Athens, Greece), D. Bouros (Athens, Greece)
Effect of Antifibrotic Therapies in Patients with Interstitial Pneumonia with Autoimmune Features A. Nagy (Budapest, Hungary), E. Bárczi (Budapest, Hungary), A. Farkas (Budapest, Hungary), A. Bohács (Budapest, Hungary), K. Vincze (Budapest, Hungary), N. Eszes (Budapest, Hungary), T. Erdélyi (Budapest, Hungary), A. Tarnoki (Budapest, Hungary), D. Tarnoki (Budapest, Hungary), V. Müller (Budapest, Hungary)
Consistent effect of nintedanib on reducing FVC decline across interstitial lung diseases (ILDs) F. Bonella (Essen, Germany), T. Maher (London, United Kingdom), V. Cottin (Lyon, France), C. Valenzuela (Madrid, Spain), M. Wijsenbeek (Rotterdam, Netherlands), F. Voss (Ingelheim am Rhein, Germany), K. Rohr (Ingelheim am Rhein, Germany), S. Stowasser (Ingelheim am Rhein, Germany)
Does excluding subjects with features similar to IPF affect the results of the INBUILD trial of nintedanib? L. Richeldi (Rome, Italy), A. Wells (London, United Kingdom), V. Cottin (Lyon, France), B. Crestani (Paris, France), M. Molina Molina (Barcelona, Spain), R. Goeldner (Biberach, Germany), S. Stowasser (Ingelheim am Rhein, Germany), R. Schlenker-Herceg (Ridgefield, CT, United States of America), Y. Inoue (Sakai City, Osaka, Japan)
High molecular weight hyaluronic acid decorated-liposome as targeted drug delivery system for fibrotic lung disorders L. Pandolfi (Pavia, Italy), A. Marengo (Paris, France), V. Frangipane (Pavia, Italy), N. Tsapis (Paris, France), S. Bozzini (Pavia, Italy), M. D'Amato (Pavia, Italy), M. Morosini (Pavia, Italy), S. Mbiandjeu (Pavia, Italy), P. Soprano (Pavia, Italy), M. Monti (Pavia, Italy), G. Comolli (Pavia, Italy), A. Balduini (Medford, Massachusetts, United States of America), S. Arpicco (Turin, Italy), E. Fattal (Paris, France), F. Meloni (Pavia, Italy)
Alterations in 24 hours blood pressure monitoring in patients with prolonged hypoxia due to interstitial lung disease V. Martínez Vázquez (Ciudad de Mexico, Mexico), M. Quintero Martínez (Ciudad de Mexico, Mexico), A. Orea Tejeda (Ciudad de Mexico, Mexico), D. Gonzalez Islas (Ciudad de Mexico, Mexico), R. Sanchez Santillan (Ciudad de Mexico, Mexico), Y. Gastelum Ayala (Ciudad de Mexico, Mexico), O. Martínez Reyna (Ciudad de Mexico, Mexico), N. Martínez Luna (Ciudad de Mexico, Mexico), I. Pérez Garcia (Ciudad de Mexico, Mexico), A. Sandoval Sanchez (Ciudad de Mexico, Mexico), M. Gómez Martínez (Ciudad de Mexico, Mexico), L. Verdeja Vendrell (Ciudad de Mexico, Mexico), I. Buendía Roldan (Ciudad de Mexico, Mexico), M. Mejía Ávila (Ciudad de Mexico, Mexico), R. Robles Hernandez (Ciudad de Mexico, Mexico)
Many-faced histological patterns of hypersensitivity pneumonia: the insights to diagnostics M. Samsonova (Moscow, Russian Federation), N. Trushenko (Moscow, Russian Federation), A. Cherniaev (Moscow, Russian Federation), K. Mikhailicheko (Moscow, Russian Federation), J. Omarova (Moscow, Russian Federation), S. Avdeev (Moscow, Russian Federation)
Concordance of pre transplant radiological diagnosis  with posttransplant explant histology of interstitial lung disease (ILD): A single centre study from India. H. Sandeepa (BANGALORE, India), V. Rahulan (ChennaiBANGALORE, India), A. Jindal (ChennaiChennaiBANGALORE, India), V. Bellad (BangaloreChennaiChennaiBANGALORE, India), B. B V (BangaloreChennaiChennaiBANGALORE, India), S. S (BangaloreChennaiChennaiBANGALORE, India), P. Dutta (ChennaiBangaloreChennaiChennaiBANGALORE, India), P. Yadav (Chennai, India), S. Attawar (Chennai, India)
Usefulness and safety of transbronchial lung cryobiopsy for reassessment of treatment in the clinical course of diffuse lung disease Y. Sato (Yokohama, Japan), T. Baba (Yokohama, Japan), K. Higa (Yokohama, Japan), R. Ootoshi (Yokohama, Japan), R. Shintani (Yokohama, Japan), T. Oda (Yokohama, Japan), H. Kitamura (Yokohama, Japan), Y. Okudela (Yokohama, Japan), T. Iwasawa (Yokohama, Japan), T. Takemura (Yokohama, Japan), T. Ogura (Yokohama, Japan)
CAR T cells-associated delayed lung toxicity – a case series L. Bondeelle (Paris, France), R. Di Blasi (Paris, France), L. Samy (Paris, France), L. Aguinaga (Paris, France), G. Lorillon (Paris, France), S. Bernard (Paris, France), C. Thieblemont (Paris, France), A. Bergeron Lafaurie (Paris, France)
Effect of tocilizumab on interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA) N. Otsuji (koshigaya, Japan), K. Sugiyama (koshigaya, Japan), H. Arifuku (koshigaya, Japan), K. Nakano (koshigaya, Japan), H. Watanabe (koshigaya, Japan), T. Wakayama (koshigaya, Japan), K. Koyama (koshigaya, Japan), H. Hirata (koshigaya, Japan), Y. Fukushima (koshigaya, Japan)
Impulse oscillometry (IOS) in Interstitial Lung Diseases: clinical- functional- radiological correlations. S. Soave (Rovigo, Italy), F. Bellini (Rovigo, Italy), O. Nori (Ferrara, Italy), A. Carnevale (Ferrara, Italy), M. Contoli (Ferrara, Italy), A. Papi (Ferrara, Italy), G. Casoni (Rovigo, Italy)
Experimental modeling of lung involvement due to systemic sclerosis. B. Doskaliuk (Ivano-Frankivsk, Ukraine), L. Zaiats (Ivano-Frankivsk, Ukraine), R. Yatsyshyn (Ivano-Frankivsk, Ukraine)
Seventeen cases of “IgG4-positive interstitial pneumonia” characterized by elevated serum IgG4 levels and IgG4-positive plasma cell infiltrations in the lungs . Komatsu (Matsumoto, Japan), H. Yamamoto (Matsumoto, Japan), S. Matsui (Toyama, Japan), T. Baba (Yokohama, Japan), A. Miyamoto (Tokyo, Japan), T. Handa (Kyoto, Japan), K. Tomii (Kobe, Japan), Y. Waseda (Fukui, Japan), M. Bando (Shimono, Japan), H. Ishii (Tokyo, Japan), Y. Miyazaki (Tokyo, Japan), T. Iwasawa (Yokohama, Japan), T. Johkoh (Amagasaki, Japan), A. Yoshizawa (Kyoto, Japan), Y. Terasaki (Tokyo, Japan), A. Hebisawa (Asahi, Japan), T. Takemura (Yokohama, Japan), Y. Kawabata (Kumagaya, Japan), M. Hanaoka (Matsumoto, Japan), T. Ogura (Yokohama, Japan)
Bioelectrical impedance analysis (BIA) and physical fitness in patients with idiopathic pulmonary fibrosis (IPF) L. Gallotti (naples, Italy), A. Stanziola (naples, Italy), A. Di Gregorio (naples, Italy), l. capitelli (naples, Italy), F. De Blasio (naples, Italy), P. Alicante (naples, Italy), L. Scalfi (naples, Italy), A. Sanduzzi Zamparelli (naples, Italy), M. Bocchino (naples , Italy)
The predictors of diffuse alveolar damage in autopsy cases with acute respiratory distress syndrome R. Imai (Tokyo, Japan), R. Shosei (Tokyo, Japan), M. Murakami (Tokyo, Japan), K. Okafuji (Tokyo, Japan), A. Kitamura (Tokyo, Japan), Y. Tomishima (Tokyo, Japan), T. Jinta (Tokyo, Japan), N. Nishimura (Tokyo, Japan), T. Tamura (Tokyo, Japan)
Diagnostic accuracy and safety of inhalation challenge tests for bird fancier’s lung Z. Jin (Kamogawa, Japan), A. Shiroshita (Kamogawa, Japan), Y. Tanaka (Kamogawa, Japan), K. Nakashima (Kamogawa, Japan), Y. Kataoka (Amagasaki, Japan)
INTERSTITIAL LUNG DISEASE ASSOCIATED WITH CONNECTIVE TISSUE DISEASE (CTD-ILD): RETROSPECTIVE MULTICENTRIC STUDY M. Garcia Moyano (Barakaldo, Spain), F. Vivero Acosta (Mar del Plata, Argentina), D. Martin Iglesias (Barakaldo, Spain), J. Enghelmayer (Buenos Aires, Argentina), D. Lancellotti (Mar del Plata, Argentina), A. Gaser (Buenos Aires, Argentina), F. Campins (Mar del Plata, Argentina), J. Sebastiani (Mar del Plata, Argentina), P. Malfante (Mar del Plata, Argentina), G. Ruiz Irastorza (Barakaldo, Spain)